Statin Use in Patients With IBD Tied to Lower PSC Risk

Statin use may contribute to a significant reduction in the risk for new primary sclerosing cholangitis among patients with inflammatory bowel disease.

Related Keywords

Boston ,Massachusetts ,United States ,California ,Washington ,Chiraag Kulkarni ,Gyongyi Szabo ,Stanford California University School Of Medicine ,Beth Israel Deaconess Medical Center ,Digestive Disease Week ,University School ,Biliary Section Distinguished Abstract Plenary ,